LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients
Hepatology,  Clinical Article

Ito K et al. – The efficacy of LecT–Hepa, a glyco–marker developed using glycoproteomics, for estimating liver fibrosis was demonstrated in a multicenter study. LecT–Hepa given by a combination of the 2 glyco–parameters is a reliable method for determining the fibrosis stage, and is a potential substitute for liver biopsy.

Methods
  • Overall, 183 CHC patients were recruited from 5 liver centers.
  • The parameters Aspergillus oryzae lectin [AOL]/Dature stramonium lectin [DSA] and Maackia amurensis lectin [MAL]/DSA were measured using a bedside clinical chemistry analyzer in order to calculate LecT-Hepa levels.
  • The data were compared with those of 7 other noninvasive biochemical markers and tests (hyaluronic acid, tissue inhibitor of metalloproteases-1, platelet count, APRI, Forns index, Fib-4 index, and Zeng's score) for assessing liver fibrosis using the receiver-operating characteristic curve.
  • LecT-Hepa correlated well with the fibrosis stage as determined by liver biopsy.

Results
  • The area under the curve (AUC), sensitivity and specificity of LecT-Hepa were 0.802, 59.6%, and 89.9%, respectively, for significant fibrosis; 0.882, 83.3%, and 80.0%, respectively, for severe fibrosis; and 0.929, 84.6%, and 88.5%, respectively, for cirrhosis.
  • AUC scores of LecT-Hepa at each fibrosis stage were greater than those of the 7 aforementioned noninvasive tests and markers.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Gastroenterology Articles

1 Screening prior to biological therapy in Crohn's disease: Adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study Digestive and Liver Diseases, August 4, 2014    Clinical Article

2 The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence following surgery for Crohn's disease Clinical Gastroenterology and Hepatology , November 7, 2014    Clinical Article

3 Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes Autoimmunity Reviews, November 19, 2014    Evidence Based Medicine    Review Article

4 Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases Full Text World Journal of Gastroenterology, November 17, 2014    Free full text    Clinical Article

5 Magnetic resonance enterocolonography is highly detectable of erosion and redness in intestinal mucosa of patients with Crohn's disease Journal of Gastroenterology and Hepatology, November 20, 2014    Clinical Article

6 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , June 25, 2014    Evidence Based Medicine    Clinical Article

7 Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients Clinical Gastroenterology and Hepatology , September 19, 2014    Clinical Article

8 Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study Annals of Internal Medicine, November 11, 2014    Evidence Based Medicine    Clinical Article

9 Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50years Journal of Crohn's and Colitis, September 8, 2014    Clinical Article

10 Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the help randomized clinical trial JAMA Internal Medicine, October 13, 2014    Evidence Based Medicine    Clinical Article

11 The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children Journal of Crohn's and Colitis, November 3, 2014    Clinical Article

12 The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: A national population-based study of incident cases between 1989–2009 Alimentary Pharmacology and Therapeutics, November 12, 2014    Clinical Article

13 Consumption of garlic and risk of colorectal cancer: An updated meta-analysis of prospective studies Full Text World Journal of Gastroenterology, November 18, 2014    Free full text    Evidence Based Medicine

14 Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals Alimentary Pharmacology and Therapeutics, October 27, 2014    Clinical Article

15 Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients Alimentary Pharmacology and Therapeutics, November 4, 2014    Clinical Article

16 Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: A systematic review Canadian Journal of Gastroenterology, November 12, 2014    Review Article

17 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , September 25, 2014    Clinical Article

18 The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease Gut, November 13, 2014    Clinical Article

19 High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection Clinical Gastroenterology and Hepatology , November 21, 2014    Clinical Article

20 Risk of upper gastrointestinal bleeding from different drug combinations Gastroenterology, October 13, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore